Objectives. The Goals of the TVT Registry. STS/ACC TVT Registry Update March 27, John D. Carroll, MD TVT Registry Steering Committee Liaison
|
|
- Anis Hodge
- 5 years ago
- Views:
Transcription
1 STS/ACC TVT Registry Update March 27, 2014 John D. Carroll, MD TVT Registry Steering Committee Liaison Objectives Provide an overview of past and present registry activities Demonstrate the benefits of the TVT Registry 2 The Goals of the TVT Registry Learn from patient-level data Regulatory device surveillance Quality improvement Insights into patient selection, etc. Feedback, benchmarking, and best practices at a site level Patient education and informed decision-making Research important hypotheses tested to expand our understanding Be a driving force in improving our health care system 1
2 2002, Rouen, F.I.M TAVR Moving from concept to clinical execution Oh! my God! Day-8 July 2011 Nov 2011 Dec 2011 May 2012 Feb 2013 Sept 2013 Oct 25, 2013 Jan 17, 2014 May 18, 2014 May 2014 TVT Registry proposed at FDA Advisory Panel for Edwards Sapien Valve FDA Approves Edwards Sapien THV STS/ACC TVT Registry Launched Version 1.0 CMS issued National Coverage Decision STS/ACC TVT Registry Launched Version 1.2 STS/ACC TVT Registry Launched Version 1.3 FDA Approves Abbott MitraClip FDA Approves Medtronic CoreValve Anticipated Decision for NCD for MitraClip STS/ACC TVT Registry Launch for 2.0 Governance Structure of the TVT Registry 2
3 Members David Holmes Michael Mack John Rumsfeld Fred Edwards Eric Peterson Cynthia Shewan Kathleen Hewitt Members Fred Edwards (chair) Dave Cohen Eric Peterson Dave Shahian John Rumsfeld DCRI Project Team Sean O Brien Matthew Brennan Dadi Dai Michael Booth Risk Model Group The primary goal of the Work Group is to develop models (mortality, bleeding) used in TVT Registry Institutional Outcome Reports for benchmarking purposes. Other risk models, such as one estimating individual patient risk may follow. The initial model compares in-hospital mortality across participating centers, potentially identifying outliers as more data accumulate in the Registry. All 13,218 Cases are Commercial TAVR 272 Sites Enrolled in TVT Registry 258 Sites Entering Data 5 Sites > 200 Cases; 24 Sites > 100 Cases Does Not Include All TAVR Cases in US Over 10K Cases from IDE Trials Some Commercial TAVR Cases Before NCD, VA Cases 3
4 Distribution of Sites by Annual Volume Number of Sites Note: Investigative case volume at sites isnot counted < Annualized Volume Groups Source: STS/ACC TVT Registry Database Sites Participating in TVT Registry (Currently TAVR) No TAVR sites in Alaska and Wyoming (currently patients served by Seattle and Colorado sites) 1. As of last week 272 TAVR sites fully enrolled. Additional sites being trained by Edwards and Medtronic will be added. 2. Approximately 35 sites who have started commercial MitraClip use are already TAVR-TVT sites. STS/ACC TVT Registry Data Quality Program 4
5 Data Quality Program Pre data collection Data submission Post data submission Software Training Clinical support Data quality reports Adjudication Audit Outlier program Publications Data Quality Program Post Submission Adjudication Verifies and provides additional information for key events (stroke, TIA and repeat intervention, plus CHF admission for MitraClip) National audit program (starts in 2014) Evaluates accuracy and reliability Assesses proper and complete reporting of cases Voluntary and self audits Data Outlier Program Provides outlier alerts to Registry participants Adjudication Process: Additional Data and Physician Review at DCRI 5
6 KCCQ Data Completeness Update Improvements & Expansion in Data Elements and Modular Design Version Reduction of site burden in TAVR data collection based on lessons learned 2. Expansion to include CoreValve technology 3. Development of Mitral Module to include MitraClip technology 4. Formation of Three Separate TVT Registry Modules Transcatheter Aortic Valve Replacement STS-ACC TVT Registry Three Modules in 2.0 Release Transcatheter Mitral Valve Repair Transcatheter Mitral Valve Replacement Types Native Valve-in-Valve Technologies Sapien TM CoreValve TM Types Direct Leaflet Technologies MitraClip TM Future Additions Annular Reduction Types Native Valve-in-Valve Valve-in-Ring Technologies Sapien TM Relevant Issues Commercially approved Melody TM valve in separate NCDR registry Potential Areas of Expansion in TVT Arena? Mitral balloon commissurotomy Para-prosthetic valve regurgitation repair with transcatheter plugs 6
7 STS Members Fred Edwards Patrick McCarthy Craig Miller Echo Specialists Paul Grayburn *** Neil Weissman TVT Registry Mitral Module Workgroup Composition ACC Members John Carroll - Chair Samir Kapadia Data Analytic Center (DCRI) FDA - John Laschinger*** STS, DCRI and ACC Staff Cynthia Shewan and Donna McDonald STS Michael Booth and Paul Meehan - DCRI Joan Michaels and Susan Fitzgerald ACC *** Heart Failure Specialists Maggie Redfield JoAnn Lindenfeld FDA CMS Stakeholders Industry ACC and STS leadership Analytic Centers Users (public comment period) Abbott Input Barathi Sethuraman Bhagya Gurusu Liz McDermott Mitral Module and CMS CMS held an open comment period for a National Coverage Decision for MitraClip procedures NCD expected May 2014 Data Elements and Definitions Aligned with VARC2 endpoints Harmonized with STS and ACC-NCDR data elements where possible Data elements and definitions reviewed and approved by Industry, CMS and FDA 8 page DCF 7
8 Health Status (KCCQ) Six Minute Walk 30 day and 1 year follow-up Adjudication of TIA/Stroke Re-interventions Heart failure readmission Data Elements and Definitions Pre-Procedure Echocardiogram Assessment Kudos to Paul Grayburnand further guidance from Neil Weissman According to ASE Guidelines integrated approach Improvements in TAVR Module in Version 2.0 Reduction in number of data elements Current version = 343 Version 2.0 = 308 with 38 data elements eliminated Added UDI field Added fields to assess disability from stroke without requiring burdensome Rankin score Social/Recreational Activities Impaired Neurocognitive Functions Essential to Patient Impaired New Aids or Assistance Required 8
9 Improvements & Expansion in Data Elements and Modular Design Version Reduction of site burden in TAVR data collection based on lessons learned 2. Expansion to include CoreValve technology 3. Development of Mitral Module to include MitraClip technology 4. Formation of Three Separate TVT Registry Modules STS-ACC TVT Registry as the Leading Edge of the Learning Health Care System in the United States Observingwhat is happening every day. Reportingfor all to see. Developingresearch proposals to be objective and scientific. Learning and becoming wiser. Acting to improve patient care. 9
10 Reporting from the TVT Registry Presentations at Major Meetings: TCT, STS, CRT, ACC, etc. Abstracts Manuscripts Reporting on TVT Registry Data But Also Demonstrating the Added Impact from Links to Other Registries and Databases ACC 2014 Late-Breaking Clinical Trial: One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry. David R. Holmes, J. Matthew Brennan, John Rumsfeld, Dadi (David) Dai, Fred Edwards, John Carroll, David Shahian, Frederick Grover, E. Murat Tuzcu, Eric Peterson, Ralph Brindis, Michael Mack. CMS has successfully linked the STS/ACC TVT Registry to inpatient Medicare claims using direct patient identifiers with a roughly 97% record linkage rate across more than 7,500 TAVR cases from Nov 2011 through October Additional Abstract Presentations 10
11 Pre-Procedure Status NYHA Functional Class 77% Five Meter Walk Test Missing: 2% No = not performed: 59% Yes = performed: 36% Unable to walk: 4% KCCQ-12 46% July % May % Completeness of Data DCRI Analysis 9/13/2013 n = 7797 cases Data Fields: Range of Complete data Pre-Procedure Status Clinical Data(labs, PFTs): 10 elements 43%- 100% DLCO 43% Pre-Procedure Meds: 5 elements % Pre-Procedure Status: Cath and Echo Data: 30 elements % Left atrial area 32% Improvements in TAVR Module in Version 2.0 Reduction in number of data elements Current version = 343 Version 2.0 = 308 with 38 data elements eliminated Added UDI field Added fields to assess disability from stroke without requiring burdensome Rankin score Social/Recreational Activities Impaired Neurocognitive Functions Essential to Patient Impaired New Aids or Assistance Required 11
12 Who is Undergoing TAVR in the USA? Demographics: Age, Sex, Race, Ethnicity The Baby Boomers are Coming and US Demographics are Shifting in Race/Ethnicity Women What Does the STS-ACC TVT Registry Show? (N= 7710 Patient Records) Expected Percentage of TAVR Patients Who are Predicted to be Women Based on US Census, TAVR Age Data, and Assumed Disease Frequency 61.9% WHY the difference? Actual Percentage of TAVR Patients Who are Women 49.1% Black-African/Americans What Does the STS-ACC TVT Registry Show? 7710 Patient Records Expected Percentage of TAVR Patients Who are Predicted to be Black Based on US Census, TAVR Age Data, and Assumed Disease Frequency 9% WHY the difference? Actual Percentage of TAVR Patients Who are Black 3.6% 12
13 Research and Publications Committee STS Members Fred Edwards Vinod Thourani Jeffrey Jacobs Todd Dewey ACC Members John Rumsfeld David Cohen Neal Kleiman Ajay Kirtane Registry Operations Center NCDR Ex Officio Members FDA Art Sedrakyan Biostats - Eugene Blackstone DCRI Eric Peterson Staff Tina Kourtis Mary Weideman, Joan Michaels, Kathleen Hewitt, Research and Publications Initial Phase: Steering Committee Members to Provide the First Wave of Strategic Presentations and Publications Current Phase: January 2014 the R & P Committee accepted outside research proposals for using the TVT Registry data 80 proposals were received! R & P committee now performing reviews and establishing priorities Post-Approval Studies, IDE s, and Uses of Registry Data for Expansion of Indications STS-ACC actively involved with discussions with FDA How are data collected in observational registries? How can data be used to support post-approval studies and investigative device exemptions ( IDE s )? What are the applicable informed consent requirements? How to best utilize the vast amount of patient-level data while assuring the safety and protection of human subjects and imposing the least burden on the sponsors and participating hospitals? 13
14 Outcomes from TAVR and Surgical AVR Is Consumer Level Reporting Coming? Outcomes of TAVR at Different Sites How and when can the TVT registry provide an analysis of outcomes per site that is credible and actionable? 1. To assist patient, families, and clinicians in site selection 2. To provide CMS, professional societies, and medical device companies on the success of the current site qualification standards used in the NCD 3. To provide guidance on whether the number of TAVR sites should be further expanded with less stringent qualifications 4. To determine learning curve effects, the volume-outcome relationship in TAVR, and the determination of best practices to improve outcomes 5. To start a dialogue on how sites with poor outcomes should be approached. Step #1: Outcomes Must Be Adjusted to The Characteristics of the Patients Being Treated Is the observed outcome equal, less, or more than predicted for a site s patients? The risk-model development group: Fred Edwards and others The first TVTR risk model should be available in May
15 Other Factors Determining Outcomes TAVR technology is changing and the TVT Registry should show substantial changes (reductions) of many complications as new and better valves/delivery systems are approved. The learning curve continues to operate for the whole community and individual sites. Identification of patients who may have underlying characteristics predicting a poor outcome may help guide centers in the key issue of patient selection Other Lessons Learned in Judging Sites Statistical assessment of sites with low volumes is problematic. Geographical distribution of sites is key for patient access Assuming 1. Patients, Families, and Clinicians Have Access to TAVR and savr 2. Sites Have Outcomes That Are at Least as Good as Expected How Can The TVT Registry Be Used to Help Patients, Families, and Clinicians in Key Patient-Centric Decisions? 15
16 Optimizing Health Outcomes in Patients with Symptomatic Aortic Valve Disease. PICORI Grant Awarded Late 2013 Matthew Brennan, MD Principle Investigator DCRI Research Goal: Help patients make informed treatment decisionsthat incorporate their preferences and outcomes of interest 1. Creation and assessment of statistical prediction models accurate and valid patient-level predictions of outcomes for patients with severe aortic stenosis treated with SAVR vs. TAVR. 2. Creation of decision assistance tools suitable for use by patients Surgical candidates A second tool for patients who have surgically inoperable disease. 3. Dissemination of these tools into clinical practice using a webbased platform coupled with a pilot evaluation of their effectiveness 16
17 Is it a reasonable goal for the TVT Registry to replace the MDR system? Why? How? When? Challenges: Harmonization of data elements Replacing free text with? Adjudication process by professional societies? process, timing, and responsibilities of reportable events need clarification Questions? 17
Objectives. The Goals of the TVT Registry
STS/ACC TVT Registry From Beginning to Now Joan Michaels, RN, MSN, CPHQ, AACC March 27 2014 Objectives Discuss past and present STS/ACC TVT Registry activities Identify at least two benefits to participating
More informationRegulatory Science and Sustainable Implementation of National and International Medical Device Registries
Regulatory Science and Sustainable Implementation of National and International Medical Device Registries Focus-- Cardiovascular Registries TAVR: Case Study on the Value of Collaboration Ralph Brindis,
More informationSIMPLE SOLUTIONS. BIG IMPACT.
SIMPLE SOLUTIONS. BIG IMPACT. SIMPLE SOLUTIONS. BIG IMPACT. QUALITY IMPROVEMENT FOR INSTITUTIONS combines the American College of Cardiology s (ACC) proven quality improvement service solutions and its
More informationStrategies for an Effective Structural Heart Program: Current and Future Considerations
Strategies for an Effective Structural Heart Program: Current and Future Considerations Eric L. Sarin, MD Co-Director, Structural Heart and Valve Program Co-Director, Cardiovascular Research Inova Heart
More informationOn May 1, 2012, the Centers for Medicare & Coverage Decision. How will this recent announcement affect your patients and practice?
VALVE UPDATE The TAVR National Coverage Decision How will this recent announcement affect your patients and practice? Ted E. Feldman, MD, is Director of the Cardiac Catheterization Laboratory at Evanston
More informationACC State Chapters Best Practice Guide. Working with States on Clinical Data Requests
ACC State Chapters Best Practice Guide Working with States on Clinical Data Requests Prepared by: Science, Education and Quality Division As of: 3/16/2016 Contents 1. Introduction... 1 2. NCDR Registries
More informationTHE CANADIAN CARDIOVASCULAR SOCIETY QUALITY INDICATORS E- CATALOGUE QUALITY INDICATORS FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)
THE CANADIAN CARDIOVASCULAR SOCIETY QUALITY INDICATORS E- CATALOGUE QUALITY INDICATORS FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) A CCS CONSENSUS DOCUMENT FINAL V1 Last updated: September 16, 2015
More informationApps at the Point Of Care
Apps at the Point Of Care Andrew Freeman, MD, FACC Director of Clinical Cardiology and Operations National Jewish Health Associate Professor of Medicine National Jewish Health and University of Colorado
More informationACTION Registry-GWTG. NCDR13 Updates 3/22/2013. ACTION Cumulative Records Submitted Q Q Q Q Q3 Records Submitted
ACTION Registry-GWTG NCDR13 Updates 500000 450000 400000 350000 300000 250000 200000 150000 100000 50000 0 ACTION Cumulative Records Submitted 457970 327168 219151 138117 83446 2008 Q3 2009 Q3 2010 Q3
More informationWho is our TAVR population?
The Structural Heart Disease Patient Experience Jennifer Dollery RN, BSN Structural Heart Disease Program Manager The Ohio State University Wexner Medical Center 1 Who is our TAVR population? 2 Early TAVR
More informationCalendar Year 2014 Medicare Physician Fee Schedule Final Rule
Calendar Year 2014 Medicare Physician Fee Schedule Final Rule Non-Facility Cap After receiving many negative comments on this issue from physician groups, along with the House GOP Doctors Caucus letter
More informationInvestigator s Guide to NCDR Research
Investigator s Guide to NCDR Research Table of Contents WELCOME... 4 OVERVIEW... 5 NCDR Data Registries... 5 NCDR Research... 5 NCDR Data Analytics... 5 Human Subject Research and the NCDR... 6 NCDR RESEARCH
More informationSBAR: NCDR Registries Initiation and Feedback Phase
SBAR: NCDR Registries Initiation and Feedback Phase Title: NCDR Registries CECCV-36 Situation: Less than ~76% of TH procedure sites belong to NCDR Registries. Background: Registries ensure evidenced-based
More informationThe Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial The Value of Remote Monitoring
The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial The Value of Remote Monitoring George H. Crossley, MD President, Mid State Cardiology, a unit of St. Thomas
More informationHow to build a TAVI Team
How to build a TAVI Team TAVI Summit, Seoul, Korea, September 3rd, 2011 Alain Cribier, MD Charles Nicolle Hospital, University of Rouen, France Disclosure Consultant and involved in the Training / Proctoring
More informationWorkshop #10: IMPACT Registry Data Quality Reports. Presenter Disclosure Information. Objectives 2/25/2013
Workshop #10: IMPACT Registry Data Quality Reports Presenter Disclosure Information Joanne Chisholm RN, BSN, CEN Joshua Kanter MD, FACC Kristina McCoy MSN, CPHQ, NP-C Joan Michaels RN, MSN, CPHQ The following
More informationFDA Vision for Innovative Surveillance of Orthopedic Implants
FDA Vision for Innovative Surveillance of Orthopedic Implants Danica Marinac-Dabic, MD, PhD Director, CDRH Division of Epidemiology Head, FDA ICOR Initiative Total and Resurfacing Hip Systems: Post-Approval
More informationPragmatic Trial Designs Capturing Endpoints and Integrating Data from Non-Linked Sources
Pragmatic Trial Designs Capturing Endpoints and Integrating Data from Non-Linked Sources Matthew T. Roe, MD, MHS Duke Clinical Research Institute Conflict of Interest Statement Matthew T. Roe, MD, MHS
More informationThe transcatheter aortic valve replacement (TAVR)
TM, LLC Inside One of the Nation s First Transcatheter Aortic Valve Replacement Hospitals Interview by Stephanie Wasek This article features an interview with Lisa Walsh, RN, clinical research nurse supervisor
More informationTranscatheter Aortic Valve Replacement (TAVR): A Needs Assessment for Norton Healthcare
University of Kentucky UKnowledge DNP Projects College of Nursing 2016 Transcatheter Aortic Valve Replacement (TAVR): A Needs Assessment for Norton Healthcare Anna Chumbley University of Kentucky, katiechumbley@yahoo.com
More information2018 Collaborative Quality Initiative Fact Sheet
2018 Collaborative Quality Initiative Fact Sheet Blue Cross Blue Shield of Michigan Cardiovascular Consortium Overview The Blue Cross Blue Shield of Michigan Cardiovascular Consortium, commonly called
More informationMeasure Applications Partnership
Measure Applications Partnership All MAP Member Web Meeting November 13, 2015 Welcome 2 Meeting Overview Creation of the Measures Under Consideration List Debrief of September Coordinating Committee Meeting
More informationAbout the Report. Cardiac Surgery in Pennsylvania
Cardiac Surgery in Pennsylvania This report presents outcomes for the 29,578 adult patients who underwent coronary artery bypass graft (CABG) surgery and/or heart valve surgery between January 1, 2014
More informationRegulatory Compliance Risks. September 2009
Rehabilitation Regulatory Compliance Risks September 2009 1 Agenda - Rehabilitation Compliance Risks Understand the basic requirements for Inpatient Rehabilitation Facilities (IRFs) and Outpatient Rehabilitation
More informationMDEpiNet RAPID Meeting
MDEpiNet RAPID Meeting BUILD, PCORnet & SENTINEL: Background, Data Model and Data Elements Jeffrey Brown, PhD Associate Professor May 25, 2017 1 FDA Sentinel: Background 2007: FDA Amendments Act A mandate
More informationDA: November 29, Centers for Medicare and Medicaid Services National PACE Association
DA: November 29, 2017 TO: FR: RE: Centers for Medicare and Medicaid Services National PACE Association NPA Comments to CMS on Development, Implementation, and Maintenance of Quality Measures for the Programs
More informationBricks and Mortar of a Telehealth Initiative
Bricks and Mortar of a Telehealth Initiative Session 279, Date of Session: March 8, 2018 Suzanne Richardson, MSN-HCSM, RN Laurie Eccleston, MPA, RN, CPHIMS 1 Conflict of Interest Suzanne E. Richardson,
More informationStructural Heart Program Staffing Considerations- Effective Models for Clinic, Procedure and Post Procedure Care
Structural Heart Program Staffing Considerations- Effective Models for Clinic, Procedure and Post Procedure Care Deborah Campbell Inova Fairfax Medical Campus Edwards Healthcare Leadership Series September
More informationPennsylvania Patient and Provider Network (P3N)
Pennsylvania Patient and Provider Network (P3N) Cross-Boundary Collaboration and Partnerships Commonwealth of Pennsylvania David Grinberg, Deputy Executive Director 717-214-2273 dgrinberg@pa.gov Project
More informationThe STAAR Initiative
The STAAR Initiative A quality effort at the heart of system redesign Amy E. Boutwell, MD, MPP The Center for Innovative Healthcare Strategies amy@innovativehealthcarestrategies.org Please note: Dr Boutwell
More information4/9/2016. The changing health care market THE CHANGING HEALTH CARE MARKET. CPAs & ADVISORS
CPAs & ADVISORS experience support // ADVANCED PAYMENT MODELS: CJR Eric. M. Rogers MEd. RT(R) Managing Consultant The changing health care market THE CHANGING HEALTH CARE MARKET HHS goal of 30% of traditional
More informationA strategy for building a value-based care program
3M Health Information Systems A strategy for building a value-based care program How data can help you shift to value from fee-for-service payment What is value-based care? Value-based care is any structure
More informationINTERMACS has a Key Role in Reporting on Quality Metrics
INTERMACS has a Key Role in Reporting on Quality Metrics Robert L Kormos MD FACS, FAHA FRCS(C) Director Artificial Heart Program University of Pittsburgh Medical Center The Patient Protection and Affordable
More informationNew York State Department of Health Innovation Initiatives
New York State Department of Health Innovation Initiatives HCA Quality & Technology Symposium November 16 th, 2017 Marcus Friedrich, MD, MBA, FACP Chief Medical Officer Office of Quality and Patient Safety
More informationUsing the National Hospital Care Survey (NHCS) to Identify Opioid-Related Hospital Visits
Using the National Hospital Care Survey (NHCS) to Identify Opioid-Related Hospital Visits Carol DeFrances, Ph.D. and Margaret Noonan, M.S. Division of Health Care Statistics National Center for Health
More informationCatherine Porto, MPA, RHIA, CHP Executive Director HIM. Madelyn Horn Noble 3M HIM Data Analyst
1 Catherine Porto, MPA, RHIA, CHP Executive Director HIM Madelyn Horn Noble 3M HIM Data Analyst University of New Mexico Hospitals» The state s only academic medical center» The primary teaching hospital
More informationMedicare Hospital Inpatient Prospective Payment System for Acute Care Hospitals Final 2016 Rates & Policies 1
Medicare Hospital Inpatient Prospective Payment System for Acute Care Hospitals Final 2016 Rates & Policies 1 Cardiac Rhythm Management (CRM) Market Impacts Introduction On August 3, 2015, the Centers
More informationLESSONS LEARNED IN LENGTH OF STAY (LOS)
FEBRUARY 2014 LESSONS LEARNED IN LENGTH OF STAY (LOS) USING ANALYTICS & KEY BEST PRACTICES TO DRIVE IMPROVEMENT Overview Healthcare systems will greatly enhance their financial status with a renewed focus
More informationPreliminary Evaluation Findings NJHI-Expecting Success in Cardiac Care
Preliminary Evaluation Findings NJHI-Expecting Success in Cardiac Care Presentation to the NJHI-ES Learning Network May 12, 2009 Joel Cantor, ScD Professor and Director Acknowledgements Funded by the Robert
More informationThe Medicare Local Coverage Determination Process and Clinical Trials
The Medicare Local Coverage Determination Process and Clinical Trials Richard K. Baer, M.D. Medical Director, National Government Services Health Care Compliance Association 6500 Barrie Road, Suite 250,
More informationAHRQ Quality Indicators. Maryland Health Services Cost Review Commission October 21, 2005 Marybeth Farquhar, AHRQ
AHRQ Quality Indicators Maryland Health Services Cost Review Commission October 21, 2005 Marybeth Farquhar, AHRQ Overview AHRQ Quality Indicators Current Uses of the Quality Indicators Case Studies of
More informationMOC Part IV: Your Guide to Making it Happen.
MOC Part IV: Your Guide to Making it Happen. Joseph P. Drozda, Jr., MD, F.A.C.C. Mercy, MO Paul D. Varosy, MD, F.A.C.C., FAHA, FHRS University of Colorado Denver School of Medicine, CO Disclosures Course
More informationWinning at Care Coordination Using Data-Driven Partnerships
Idriz Limaj, LNHA, RN Chief Operating Officer Winning at Care Coordination Using Data-Driven Partnerships Session #166, February 22, 2017 1 Steven Littlehale, MS, GCNS-BC EVP & Chief Clinical Officer Speaker
More informationActivity Based Cost Accounting and Payment Bundling
Activity Based Cost Accounting and Payment Bundling 1 Agenda Introduction of Speakers Fast Facts about Jewish Senior Life/Jewish Home of Rochester Determining the need and uses for an Activity Based Cost
More informationA Battelle White Paper. How Do You Turn Hospital Quality Data into Insight?
A Battelle White Paper How Do You Turn Hospital Quality Data into Insight? Data-driven quality improvement is one of the cornerstones of modern healthcare. Hospitals and healthcare providers now record,
More informationMedicare Part C Medical Coverage Policy
Clinical Trial Services Origination: June 28, 1999 Review Date: April 18, 2018 Next Review: April, 2020 Medicare Part C Medical Coverage Policy DESCRIPTION OF PROCEDURE Clinical trials (or clinical research
More informationMedicare s Impact on Cardiology Drugs and Devices During Clinical Research
Medicare s Impact on Cardiology Drugs and Devices During Clinical Research Ryan Meade, JD Meade & Roach, LLP July 15, 2008 Baltimore, Maryland University of Maryland School of Medicine 1 Overview Theme:
More informationAdditional Considerations for SQRMS 2018 Measure Recommendations
Additional Considerations for SQRMS 2018 Measure Recommendations HCAHPS The Hospital Consumer Assessments of Healthcare Providers and Systems (HCAHPS) is a requirement of MBQIP for CAHs and therefore a
More informationCardiac Certification. Achieving excellence beyond accreditation
Cardiac Certification Achieving excellence beyond accreditation Accreditation is just the beginning. 2 When it comes to accreditation, no organization can match The Joint Commission s experience and knowledge.
More informationENGAGING PHYSICIANS FOR IMPROVED OUTCOMES: CLINICAL DOCUMENTATION, FINANCIAL & PATIENT CARE
ENGAGING PHYSICIANS FOR IMPROVED OUTCOMES: CLINICAL DOCUMENTATION, FINANCIAL & PATIENT CARE Northeast Ohio HFMA GHALI May 20, 2016 James Begley, MD, MS Physician Champion, ICD-10 & Medical Records Committee
More informationNCD for Routine Costs in Clinical Trials (310.1)
NCD for Routine Costs in Clinical Trials (310.1) Publication Number 100-3 Manual Section Number 310.1 Version Number 2 Effective Date of this Version 7/9/2007 Implementation Date 10/9/2007 Benefit Category
More informationThe Minnesota Statewide Quality Reporting and Measurement System (SQRMS)
The Minnesota Statewide Quality Reporting and Measurement System (SQRMS) Denise McCabe Quality Reform Implementation Supervisor Health Economics Program June 22, 2015 Overview Context Objectives and goals
More informationThe Key Principles And Characteristics Of An Effective Hospital Medicine Group
The Key Principles And Characteristics Of An Effective Hospital Medicine Group Management Infra. Adequate Resources Effective Leadership Engaged Hospitalists Quality, Safety, & Efficiency Satisfaction
More informationMACRA Frequently Asked Questions
Following the release of the Quality Payment Program Interim Final Rule, the American Medical Association (AMA) conducted numerous informational and training sessions for physicians and medical societies.
More informationMedicare / Accountable Care Organization CHS Finance Division CPE Day November 2, 2015
Medicare / Accountable Care Organization CHS Finance Division CPE Day November 2, 2015 Steve Neorr Chief Administrative Officer, Triad HealthCare Network Jeff Jones Chief Financial Officer, Cone Health
More informationHospital IQR Program ecqm Reporting. November 7, 2013
Hospital IQR Program ecqm Reporting November 7, 2013 Discussion Topics Goals, Focus and Background Hospital IQR Program Requirements Where to begin Chart-Abstracted Deadlines ecqm Deadlines What to do
More informationVeterans Health Administration: Surveillance of Cardiovascular Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease
Veterans Health Administration: Surveillance of Cardiovascular Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease Paul D. Varosy, MD Director of Cardiac Electrophysiology VA Eastern
More informationHealth Care Systems - A National Perspective Erica Preston-Roedder, MSPH PhD
Health Care Systems - A National Perspective Erica Preston-Roedder, MSPH PhD Outline Quality Overview Overview and discussion of CMS programs Increasing transparency Move from P4R to P4P Expanding beyond
More informationTOWN HALL CALL 2017 LEAPFROG HOSPITAL SURVEY. May 10, 2017
2017 LEAPFROG HOSPITAL SURVEY TOWN HALL CALL May 10, 2017 Matt Austin, PhD, Armstrong Institute for Patient Safety and Quality, Johns Hopkins Medicine 2 Leapfrog Hospital Survey Overview Annual Survey
More informationINTERGY MEANINGFUL USE 2014 STAGE 1 USER GUIDE Spring 2014
INTERGY MEANINGFUL USE 2014 STAGE 1 USER GUIDE Spring 2014 Intergy Meaningful Use 2014 User Guide 2 Copyright 2014 Greenway Health, LLC. All rights reserved. This document and the information it contains
More informationMedication Safety Quality Improvement: Collaboration to Reduce Adverse Drug Events
Medication Safety Quality Improvement: Collaboration to Reduce Adverse Drug Events Jayme Steig, PharmD, RPh Quality Improvement Specialist - Pharmacy Quality Health Associates of North Dakota Disclosure
More informationCPAs & ADVISORS. experience support // ADVANCED PAYMENT MODELS: CJR
CPAs & ADVISORS experience support // ADVANCED PAYMENT MODELS: CJR Andy M. Williams Partner BKD Eric M. Rogers Managing Consultant BKD Will McLeod VP of Patient Services McLeod Health Emily Adams Associate
More informationData Sources for Medical Device Epidemiology
Data Sources for Medical Device Epidemiology Kaiser Permanente Surgical Outcomes & Analysis Maria Inacio, PhD National Implant Registries Today s Talk* I. Necessary data elements for device surveillance
More informationCV SURGERY 30 DAY RE-ADMISSION. CMS IS WATCHING YOU, AND YOU, AND ME TOO.
CV SURGERY 30 DAY RE-ADMISSION. CMS IS WATCHING YOU, AND YOU, AND ME TOO. THE TEAM UTAH VALLEY HOSPITAL John Mitchell, MD January 16, 2016 Centers for Medicare and Medicaid Services Federally funded inpatient
More informationVNAA BLUEPRINT FOR EXCELLENCE BEST PRACTICES TO REDUCE HOSPITAL ADMISSIONS FROM HOME CARE. Training Slides
VNAA BLUEPRINT FOR EXCELLENCE BEST PRACTICES TO REDUCE HOSPITAL ADMISSIONS FROM HOME CARE Training Slides 061015 Why Take Action to Prevent Readmissions? Better patient care and patient experience Home
More informationPredicting patient survival of high- risk surgeries. Developed for The Leapfrog Group by Castlight Health
Predicting patient survival of high- risk surgeries Developed for The Leapfrog Group by Castlight Health Table of contents Introduction... 3 Predicting patient survival of high- risk surgeries... 4 Little
More information1. Measures within the program measure set are NQF-endorsed or meet the requirements for expedited review
MAP Working Measure Selection Criteria 1. Measures within the program measure set are NQF-endorsed or meet the requirements for expedited review Measures within the program measure set are NQF-endorsed,
More informationThe New Clinical Research Landscape Incentives, Opportunities and Support Offered by the NIHR
The New Clinical Research Landscape Incentives, Opportunities and Support Offered by the NIHR 1 September 2011 Dr Jonathan Gower Assistant Director CCRN The National Institute of Health Research - A real
More informationDescribe the process for implementing an OP CDI program
1 Outpatient CDI: The Marriage of MACRA and HCCs Marion Kruse, RN, MBA Founding Partner LYM Consulting Columbus, OH Learning Objectives At the completion of this educational activity, the learner will
More informationEpisode Payment Models Final Rule & Analysis
Episode Payment Models Final Rule & Analysis February 15, 2017 Agenda Overview Changes from Proposed Rule Categorization of Episodes Episode Attribution Reconciliation Quality Performance Cardiac Rehab
More informationNew federal requirements for posting of clinical trials information
in the news Health Care October 2016 New Clinical Trial Rule Alters Reporting Requirements In this Issue: Introduction... 1 Types of Clinical Trials Subject to the Final Rule... 2 The Responsible Party
More informationIntroduction to Coverage Analysis Part 1. Amanda Miller, Training Program Manager Derek McCormick, Operations Manager October 14, 2016
Introduction to Coverage Analysis Part 1 Amanda Miller, Training Program Manager Derek McCormick, Operations Manager October 14, 2016 Faculty Disclosure In compliance with ACCME Guidelines, I hereby declare:
More informationProvider Orientation to Magellan s Outpatient Behavioral Health Model
Provider Orientation to Magellan s Outpatient Behavioral Health Model July 2017 Big-picture objectives Magellan Healthcare s outpatient care management model: Reduces provider administrative tasks Expedites
More informationCreate an Evaluation Protocol for Electronic Permit Application Processing
Create an Evaluation Protocol for Electronic Permit Application Processing Janet McIlvaine, Karen Fenaughty, Jeff Sonne, and Rob Vieira University of Central Florida, Florida Solar Energy Center Rationale
More informationW. Douglas Weaver, MD, MACC. American College of Cardiology SENATE FINANCE COMMITTEE
Statement of W. Douglas Weaver, MD, MACC On behalf of the American College of Cardiology Presented to the SENATE FINANCE COMMITTEE Roundtable on Medicare Physician Payments: Perspectives from Physicians
More informationThe Memphis Model: CHN as Community Investment
The Memphis Model: CHN as Community Investment Health Services Learning Group Loma Linda Regional Meeting June 28, 2012 Teresa Cutts, Ph.D. Director of Research for Innovation cutts02@gmail.com, 901.516.0593
More informationQAPI Making An Improvement
Preparing for the Future QAPI Making An Improvement Charlene Ross, MSN, MBA, RN Objectives Describe how to use lessons learned from implementing the comfortable dying measure to improve your care Use the
More informationPatient-Centered Specialty Practice (PCSP) Recognition Program
Patient-Centered Specialty Practice (PCSP) Recognition Program Standards Workshop Part 2 2013 All materials 2013, National Committee for Quality Assurance Agenda Part 1 Content of PCSP Standards and Guidelines
More informationPatient-Centered Connected Care 2015 Recognition Program Overview. All materials 2016, National Committee for Quality Assurance
Patient-Centered Connected Care 2015 Recognition Program Overview All materials 2016, National Committee for Quality Assurance Learning Objectives Introduction to Patient-Centered Connected Care and Eligibility
More informationThe Changing Face of the Employer-Provider Relationship
The Changing Face of the Employer-Provider Relationship Cleveland Clinic Market & Network Services Shannon Schwartzenburg August 21, 2013 Cleveland Clinic Snapshot Group practice model - 120 specialties
More informationQuality Measure Indicators +Throughput Metrics + Automated Dashboard = Innovation to Improve Quality Goals
Quality Measure Indicators +Throughput Metrics + Automated Dashboard = Innovation to Improve Quality Goals DMC Harper- Hutzel Hospital The DMC is an 8 facility academic medical center Harper-Hutzel is
More informationStakeholder input is gathered in several ways. Patients are given the opportunity to provide feedback, the SWOT analysis is based on information from
Strategic Plan 27 Executive Summary The following is a summary of the information shared in this Operations Review and Plan. This plan highlights operational achievements and challenges, clinical outcomes
More informationPreparing for Your TMVr with the MitraClip
UW MEDICINE PATIENT EDUCATION Preparing for Your TMVr with the MitraClip Planning ahead This handout explains how to prepare for your transcatheter mitral valve repair (TMVr) procedure with the MitraClip.
More informationCPAs & ADVISORS PHYSICIAN POPULATION RATIOS: THE KEY TO EVALUATING PHYSICIAN NEED, AND CREATING EFFECTIVE RECRUITING, RETENTION PLANS
CPAs & ADVISORS experience ideas // PHYSICIAN POPULATION RATIOS: THE KEY TO EVALUATING PHYSICIAN NEED, AND CREATING EFFECTIVE RECRUITING, RETENTION PLANS Presented by Scott Bezjak, Partner, BKD, LLP and
More informationThe Veterans Health Administration CART Program: Integration of Real-Time Data Collection into the Process of Clinical Care
The Veterans Health Administration CART Program: Integration of Real-Time Data Collection into the Process of Clinical Care Paul D. Varosy, MD Director of Cardiac Electrophysiology VA Eastern Colorado
More informationPERSONNEL REQUIREMENTS. March 9, 2018
Seema Verma Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Hubert H. Humphrey Building 200 Independence Avenue, S.W., Room 445 G Washington, DC 20201 RE:
More informationPotential Measures for the IPFQR Program and the Pre-Rulemaking Process. March 21, 2017
Potential Measures for the IPFQR Program and the Pre-Rulemaking Process March 21, 2017 Speakers Michelle Geppi Health Insurance Specialist Centers for Medicare & Medicaid Services Erin O Rourke Senior
More informationCMS-0044-P; Proposed Rule: Medicare and Medicaid Programs; Electronic Health Record Incentive Program Stage 2
May 7, 2012 Submitted Electronically Ms. Marilyn Tavenner Acting Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Room 445-G, Hubert H. Humphrey Building
More informationChronic Disease Surveillance and Office of Surveillance, Evaluation, and Research
Chronic Disease Surveillance and Office of Surveillance, Evaluation, and Research Potentially Preventable Hospitalizations Program 2015 Annual Meeting Nimisha Bhakta, MPH September 29, 2015 Presentation
More informationRapid-Learning Healthcare Systems
Rapid-Learning Healthcare Systems in silico Research and Best Practice Adoption in Promoting Rapid Learning Sharon Levine MD July 11, 2012 NIH Training Institute for Dissemination and Implementation Rapid-Learning
More informationNATIONAL HEALTH INTERVIEW SURVEY QUESTIONNAIRE REDESIGN
National Center for Health Statistics NATIONAL HEALTH INTERVIEW SURVEY QUESTIONNAIRE REDESIGN Marcie Cynamon, Director Stephen Blumberg, Associate Director for Science Division of Health Interview Statistics
More informationQuality ID #348: HRS-3 Implantable Cardioverter-Defibrillator (ICD) Complications Rate National Quality Strategy Domain: Patient Safety
Quality ID #348: HRS-3 Implantable Cardioverter-Defibrillator (ICD) Complications Rate National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:
More informationTargeted technology and data management solutions for observational studies
Targeted technology and data management solutions for observational studies August 18th 2016 Zia Haque Arshad Mohammed Copyright 2016 Quintiles Your Presenters Zia Haque Senior Director of Data Management,
More informationMaximize the value of CHF population management programs with advanced analytics PLAYBOOK
Maximize the value of CHF population management programs with advanced analytics PLAYBOOK STEP ONE: Analyze your patient population Bend the cost curve: Learning more about your patients can lead to higher-quality
More informationAN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES
1 AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES Key Clinical Study Tasks and Activities 2 Discussion of Key Tasks and Activities 3 Development of the Clinical Protocol and Study Materials 3 Qualification
More informationHome Health Value-Based Purchasing Series: HHVBP Model 101. Wednesday, February 3, 2016
Home Health Value-Based Purchasing Series: HHVBP Model 101 Wednesday, February 3, 2016 About the Alliance 501(c)(3) non-profit research foundation Mission: To support research and education on the value
More informationNATIONAL UNIFORM BILLING COMMITTEE DATA ELEMENT SPECIFICATIONS CHANGE REQUEST GUIDELINES
NATIONAL UNIFORM BILLING COMMITTEE DATA ELEMENT SPECIFICATIONS CHANGE REQUEST GUIDELINES In order for the NUBC to properly and efficiently consider change requests, each request must be accompanied by
More informationTESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES
TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES ON CLIA AND GENETIC TESTING BEFORE THE SENATE SPECIAL
More informationUK Renal Registry 20th Annual Report: Appendix A The UK Renal Registry Statement of Purpose
Nephron 2018;139(suppl1):287 292 DOI: 10.1159/000490970 Published online: July 11, 2018 UK Renal Registry 20th Annual Report: Appendix A The UK Renal Registry Statement of Purpose 1. Executive summary
More informationFuture Proofing Healthcare: Who Knows?
Future Proofing Healthcare: Who Knows? Marcel Loh Chief Executive, Swedish Suburban Hospitals & Affiliates Swedish Health Services 2 3 4 Things do not happen. Things are made to happen. John F. Kennedy
More information